SCHEMBL13873814

SCHEMBL13873814

O=C(NCc1ccc2c(c1)CCO2)N1CCC(c2cccnc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.46
▸ WDR77 Q9BQA1 1/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ RYR2 Q92736 1/20 0.45
▸ SPR P35270 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ HSD11B1 P28845 2/20 0.42
▸ FAAH O00519 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ CYP2J2 P51589 1/20 0.41
▸ AURKA O14965 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13873843 0.89 EPHX2 (0.49) RAB9ANPC1POLBRYR2SPR
SCHEMBL2388107 0.78 NAMPT (0.55) RAB9ANPC1SPRHSD11B1PDE4B
SCHEMBL13873648 0.77 HRH3 (0.57) PRMT5WDR77RAB9ANPC1SPR
SCHEMBL13873815 0.75 CYP2C9 (0.49) PRMT5WDR77SPRHSD11B1KDM1A
SCHEMBL13873811 0.75 EPHX2 (0.55) SPRFAAHPDE4BCYP2C9EPHX2
SCHEMBL13873816 0.74 PRMT5 (0.50) PRMT5WDR77RAB9ANPC1SPR
SCHEMBL13873641 0.74 EPHX2 (0.51) PRMT5WDR77RAB9ANPC1POLB
SCHEMBL13873820 0.74 CYP2C9 (0.53) PRMT5WDR77RAB9ANPC1SPR
SCHEMBL16178801 0.73 RYR2 (0.52) RAB9ANPC1POLBRYR2FAAH
SCHEMBL13873821 0.73 EPHX2 (0.58) SPRHSD11B1CYP2C9EPHX2CYP2J2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090111791-A1 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-30 — — US disclosed
US-20090111791-A1 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-30 — — US disclosed
WO-2007106705-A1 SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND METHODS OF USING SAME BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-09-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111791-A1 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same EPHX1, EPHX2, NCEH1 PRMT5 2065/4885WDR77 2019/4885RAB9A 3811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback